North America holds a dominant share of the DNA Bowel Cancer Screening Kits Market, driven by well-established healthcare systems, strong government-supported screening programs, and increasing awareness of colorectal cancer prevention. The region benefits from high healthcare spending, widespread adoption of molecular diagnostic technologies, and growing demand for non-invasive cancer...